271: Racing for gene therapy, a pioneering approval, & startups in the lurch
The Readout Loud
00:00
Introduction
The hosts discuss the approval of a landmark gene therapy for Duchenne muscular dystrophy with age restrictions and the urgency to get children treated before their sixth birthdays. They also explore the financial challenges faced by biotech startups.
Transcript
Play full episode
